Lam le, MD
Internal Medicine · Tulsa, OKNPI 1063562981
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 164 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Kerecis Limited at 41.0% of the total. Reporting peaked in 2022 at $2,318 and has fallen 81.6% since, to $427 in 2025. Among internal medicine clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 164 payments — averaging $50.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$3K
- Integra Lifesciences Corporation$2K
- Organogenesis Inc.$1K
- Smith+Nephew$444
- AbbVie$289
- Advanced Medical Administration$226
- plus $864 from 19 others
Across 14 payments — averaging $13,069 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Convatec Inc.$147K
- Royal Biologics, Inc.$35K
What the payments were for
- Food & beverage$8,357100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 5 | $3,428 |
| Integra Lifesciences Corporation | 39 | $1,971 |
| Organogenesis Inc. | 34 | $1,136 |
| Smith+Nephew | 31 | $444 |
| AbbVie(2 entities) | 16 | $289 |
| Advanced Medical Administration | 1 | $226 |
| Inari Medical, Inc. | 4 | $221 |
| Reprise Biomedical, Inc. | 5 | $93 |
| Solventum Corporation | 3 | $84 |
| Mimedx Group, Inc. | 3 | $61 |
| Apria Healthcare LLC | 3 | $51 |
| Paratek Pharmaceuticals, Inc. | 3 | $50 |
| OVIK Health, LLC | 2 | $43 |
| KCI USA, Inc. | 3 | $41 |
| Vertex | 1 | $29 |
| 3M Company | 1 | $28 |
| Osiris Therapeutics Inc. | 2 | $25 |
| Polynovo North America LLC | 1 | $23 |
| Advanced Oxygen Therapy Inc. | 1 | $22 |
| Bsn Medical Inc | 1 | $21 |
| Averitas Pharma Inc. | 1 | $18 |
| Acera Surgical, Inc. | 1 | $15 |
| Convatec Inc. | 1 | $15 |
| Hydrofera LLC | 1 | $14 |
| Cashflow Solutions, LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$6,713
- Kerecis Omega3 SurgiClose$5,321
- Kerecis Omega3 GraftGuide$3,325
- Kerecis Omega3 Wound$422
- Kerecis Omega3 Surgibind$422
- NuShield$329
- Apligraf$308
- OMNIGRAFT$234
- PRIMATRIX$234
- MEDIHONEY$234
- TCC-EZ$234
- AMNIOEXCEL$234
- AmnioGraft$226
- PuraPly$185
- FLOWTRIEVER CATHETER, S$164
- CT THROMBECTOMY SYSTEM KIT$164
How this compares
$8,357 in reported general payments places this provider in the 90th percentile of 840 internal medicine providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SsdSilver Sulfadiazine | 102 | $1,381 |
| Doxycycline Hyclate | 63 | $895 |
| Betamethasone Dipropionate | 11 | $548 |
| Silver Sulfadiazine | 46 | $439 |
| Levofloxacin | 39 | $331 |
| Mupirocin | 11 | $82 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Tulsa
- Jesse RichardsTulsa$279K
- Madhuri LadTulsa$173K
- Stacy ChronisterTulsa$163K
- Layth Al AttarTulsa$35K
- Gerard McNultyTulsa$27K
- Peter LantzTulsa$23K
- Sudip TripathyTulsa$21K
- John RuffingTulsa$21K
- Joseph ReeseTulsa$18K
- Mark GallesTulsa$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.